Bobbie West, MD
Emergency Medical Services · Jackson, MSNPI 1346285491
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Welch Allyn at 52.4% of the total. Reporting peaked in 2021 at $384 and has fallen 59.8% since, to $154 in 2025.
Across 17 payments — averaging $41.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Welch Allyn$368
- Novo Nordisk$177
- AbbVie$38
- GSK$35
- Pfizer$34
- Merck$23
- plus $27 from 2 others
What the payments were for
- Food & beverage$33448%
- Other$36852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Welch Allyn | 2 | $368 |
| Novo Nordisk | 6 | $177 |
| AbbVie | 2 | $38 |
| GSK | 2 | $35 |
| Pfizer | 2 | $34 |
| Merck | 1 | $23 |
| Medtronic | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$701 in reported general payments places this provider in the 85th percentile of 25 emergency medical services providers in Mississippi.
See all emergency medical services providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $51,481 |
| EliquisApixaban | 30 | $28,255 |
| MounjaroTirzepatide | 20 | $22,381 |
| JardianceEmpagliflozin | 13 | $8,358 |
| XareltoRivaroxaban | 12 | $4,736 |
| SynthroidLevothyroxine Sodium | 40 | $2,270 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 23 | $2,254 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 71 | $1,243 |
| Diclofenac Sodium | 50 | $1,129 |
| Levothyroxine Sodium | 92 | $919 |
| Rosuvastatin Calcium | 105 | $848 |
| Doxycycline Hyclate | 105 | $847 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 53 | $760 |
| Pantoprazole Sodium | 60 | $731 |
| Tamsulosin Hcl | 49 | $723 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $177 | $51,48152 claims |
| PfizerEliquis | $34 | $28,25530 claims |
| AbbVieSynthroid | $38 | $2,27040 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 25 emergency medical services providers in Mississippi.
Other emergency medical services in Jackson
- Max KeelingJackson$10K
- John BrooksJackson$708
- Chester ShermerJackson$441
- Eric ZoogJackson$364
- Phillip NguyenJackson$114
- Philip LevinGulfport$748
- Amy DavisCorinth$378
- Lisa AndersonMadison$330
- Greg TavaiHattiesburg$291
- David JohnsonYazoo City$259
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.